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TO THE EDITOR
Alopecia areata (AA), the second most
common form of hair loss in humans, is
characterized by waxing and waning
focal hair loss. Alopecic foci can expand
to encompass the entire head (alopecia
totalis) or body (alopecia universalis,
AU). This cell-mediated autoimmune
disease is characterized histologically
by the ‘‘swarm of bees’’, CD4þ and
CD8þ T cells, natural killer cells, and
fewer numbers of other types of inflam-
matory cells in and around actively
growing, anagen-stage, hair follicles.
Treatment of persistent, moderate to
severe AA is palliative at best, often
with a poor outcome (Harris et al.,
2010). Investigation of AA in humans
and in nonhuman animal models,
primarily C3H/HeJ mice (Sundberg
et al., 1994), has provided new
insights. Spontaneous AA in C3H/HeJ
mice is sporadic, of low frequency, and
most commonly affects older female
mice. Full-thickness skin grafts of AA
donor skin to young unaffected,
immunocompetent, histocompatible
recipients provides a highly repro-
ducible model (McElwee et al.,
1998) useful in preclinical trials
(Sun et al., 2008).
Heat shock was used to induce a
type of AA in C3H/HeJ mice
(Wikramanayake et al., 2010) and was
used to determine whether a commer-
cially available laser comb induced
hair regrowth (Wikramanayake et al.,
2012). The laser comb received a
501(k) clearance as a device safe
for marketing by the United States
Food and Drug Administration for the
treatment of male pattern baldness
(Leavitt et al., 2009). Laser comb
treatment induced cosmetic regrowth
of the very small, focal areas of heat
shock–induced AA after 6 weeks. To test
whether the laser comb would induce
regrowth of hair in older C3H/HeJ mice
with spontaneous or graft-induced AU,
a similar treatment regimen was used.
All protocols were approved by The
Jackson Laboratory Animal Care and
Use Committee. Only C3H/HeJ female
mice (JR# 659, The Jackson Laboratory,
Bar Harbor, ME) were used. Retired
breeders were obtained and aged until
approximately 20% developed sponta-
neous AU. Twelve of these spontaneous
AU mice were used directly. Others
were used as donors for full-thickness
skin grafts to female recipients using
protocols previously described in detail
(McElwee et al., 1998). Twelve grafted
mice were aged until they developed
AU. Each group was divided into
cohorts of six mice each and treated.
One set of spontaneous and one of graft-
induced AU were held manually, and
their ventral abdominal area was
exposed for 20 seconds to the laser
comb (Hairmax Lux 9, professional 12,
laser comb, Lexington International,
Boca Raton, FL, wavelength 655 nm,
beam diameter o5 mm, divergence
57 mrad three times per week for
6 weeks). At 6 weeks, no change in
the pelage was noted, and thus treat-
ments were continued for an additional
6 weeks (12 weeks total). The second
group of spontaneous or graft-induced
mice with AA were treated in the same
manner, but the laser was not turned on
(controls). After 12 weeks, mice were
euthanized by CO2 asphyxiation, and
ventral skin was collected, fixed in
Fekete’s acid alcohol formalin, and
processed routinely for histology; next,
5-mm sections were stained with
hematoxylin and eosin, and the slides
were examined.
Mice treated with the laser on or off
and examined weekly for 6 weeks and
then continued for 6 more weeks had no
gross (Figure 1a) or histological differ-
ences in skin for either the spontaneous
or graft-induced AA mice. Histologic
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Table 1. Groups of six mice with spontaneous or full-thickness skin graft–
induced AA were treated with the laser comb for a total of 12 weeks
Test group 6 Weeks alopecia 12 Weeks alopecia AA histopathology
Laser on
Spontaneous AA 6/6 6/6 6/6
Graft-induced AA 6/6 6/6 6/6
Laser off
Spontaneous AA 6/6 6/6 6/6
Graft-induced AA 6/6 6/6 6/6
Abbreviation: AA, alopecia areata.
There were no differences between those treated with the comb turned on (test) or off (controls). All
mice were confirmed to have alopecia areata by histopathology.
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features of AA were confirmed in donor
mice and in all 24 mice used in this
study (Figure 1b). There was mild
epidermal acanthosis with moderate to
marked infiltrates of mostly lymphocytes
and fewer granulocytes in and around
late anagen-stage hair follicles with dis-
rupted outer root sheath architecture.
All 24 mice in this study had diffuse
AA with generalized hair loss and only
remnants of hair whether or not the laser
comb was turned on or off (Table 1).
Failure to reproduce the earlier laser
comb study to induce regrowth of heat
shock–induced AA in dorsal skin of
C3H/HeJ mice (Wikramanayake et al.,
2012) may be due to the heat-induced
lesions being very small, as seen in
early-stage AA, which may also wax
and wane in human AA. In the initial
laser comb study, the AA lesions were
assumed to regrow, as only laser-treated
mice responded. These results are in
contrast to the current studies using
AU mice rather than early-onset,
less severely affected AA mice. Alter-
natively, treating dorsal skin in the initial
report versus ventral skin in this study
may be an issue. However, dorsal and
ventral lesions in both spontaneous and
graft-induced lesions respond similarly
in most other studies, and thus this
seems unlikely (King et al., 2008).
An alternative issue is whether heat
shock–induced AA is representative of
human AA. The initial report showed
gross and histologic evidence that it was
indeed quite similar to the established
mouse models (Wikramanayake et al.,
2010). However, in the subsequent laser
comb study, the gross lesion illustrated
was totally different. Although the
authors stated that they confirmed
histologic lesions of AA in two mice
before treatment, their descriptions and
figures after treatment show no evidence
of AA. Rather, their sham-treated mice
(laser turned off) show normal mouse
skin in telogen, the common persistent
stage found in adult mouse skin.
The representative mouse treated with
the laser on had normal hair follicles in
late anagen (lacking clear evidence
of inflammation in and around the
follicles; Wikramanayake et al., 2012),
which is found, although infre-
quently, in adult mice (Sundberg and
Silva, 2012). Alopecia in small foci in
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Figure 1. Response of mice with alopecia universalis to a laser comb. (a) All mice, whether they had
spontaneous or full-thickness skin graft–induced alopecia areata (AA), had diffuse alopecia with sparse
defective hair shafts. Treatment with the laser comb turned on or turned off had no effect. Mice were
examined at 6 and 12 weeks after treatment with no improvement in the alopecia. (b) Microscopic
evaluation of all 24 mice had classical histological features of alopecia areata in C3H/HeJ mice. Two
representative mice from each group are illustrated. There were lymphocytes in and around anagen-stage
hair follicles, with various degrees of follicular dystrophy resulting in damaged hair shafts that broke
off at the skin surface. Boxed areas are enlarged to illustrate the details. Bar¼100mm.
LE King Jr et al.
Laser Comb for Mouse Alopecia
www.jidonline.org 265
C3H/HeJ mice can be due to AA but
also is not less commonly due to
grooming behavior abnormalities
(barbering, a form of trichotillomania).
The laser comb, as used in the original
study, potentially could induce anagen
activation in the heat shock–induced
AA of the normally quiescent mouse
telogen follicles.
In summary, laser comb treatment did
not induce hair growth in C3H/HeJ mice
with extensive AA in well-established
spontaneous arising or full-thickness
skin graft mouse models of human AA.
More work on the heat shock–induced
AA model needs to be done to define its
value in preclinical trials.
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TO THE EDITOR
We thank Kottner and Streiner (2013) for
sharing their concerns, and we read
with great interest their arguments
against ‘‘dichotomizing’’ continuous
variables. We both agree and have
points of divergence with them. The
area of agreement is large, as dichot-
omizing continuous variables is gener-
ally scientifically unsound and, as
pointed out by Kottner and Streiner
(2013), leads to loss of precision, and
therefore loss of power. As a general
rule, no continuous variable should be a
priori and arbitrarily dichotomized
before being collected, and continuous
explicative variables should be kept as
such in statistical models. We therefore
want to make it clear that we are far
from defending dichotomization for
continuous variables in general.
However, outcome criteria (we exclu-
sively focused on that type of variable in
Nassar et al., (2012)) have a specific
status, and our plea for dichotomizing
clinical outcomes in dermatology may
unveil several areas of divergence with
Kottner and Streiner’s (2013) views.
Our point is that, even when an out-
come measurement uses a score based
on a continuous variable, it is valuable
to dichotomize it secondarily. For
instance, the ‘‘PASI75’’ outcome does
exactly that. ‘‘Improvement of PASI
score’’ is a continuous variable. ‘‘Has
the patient reached a threshold of 75%
improvement of his/her PASI score, yes
or no?’’ is the dichotomization of this
continuous variable. Why is defining such
a threshold and incorporating it into the
final outcome definition, in our view,
valuable and should be encouraged?
First, dichotomization of continuous vari-
ables is pervasive in our medical practice
and should not just be seen as ‘‘an
unjustified oversimplification of a complex
reality’’ but rather as a necessary simplifi-
cation. The most common dichotomization
for almost any continuous variable is
‘‘above vs. within normal range’’. Blood
pressure is a continuous variable, but set-
ting a threshold of 140/90mmHg to define
hypertension has been deemed necessary.
Many similar examples could be found.
Second, in the domain of clinical out-
comes for inflammatory skin diseases, the
apparent continuity of most scale- and
score-based outcome measurements is a
delusion. For instance, Psoriasis Area and
Severity Index (PASI) score is actually
made of elementary categorical items
(scaling, erythema, thickness) for which
quoting a number is artificial (erythema at
‘‘4’’ does not equal—and does not
mean—4 times ‘‘1’’; and no erythema
can be quoted at 5 or 4.3 in a PASI score).
Our paper, and our statements, should beAccepted article preview online 11 June 2013; pubilshed online 11 July 2013
Abbreviation: PASI, Psoriasis Area and Severity Index
A Dupuy and D Nassar
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